Better Therapeutics Layoffs: What Happened & Why?

On March 27, 2023, Better Therapeutics laid off 35 employees, representing 0.35% of its workforce. This move reflects ongoing challenges within the company.

Headquartered in the SF Bay Area, Better Therapeutics operates in the healthcare industry. The layoffs highlight the company's efforts to navigate a competitive and evolving market landscape.

Why did Better Therapeutics have Layoffs?

Better Therapeutics decided to lay off employees as part of a cost reduction initiative aimed at extending its financial runway and reaching critical milestones, including potential FDA marketing authorization and the commercial launch of BT-001 for Type 2 diabetes. The company has struggled to reach profitability since going public in 2021, facing significant financial challenges.

• Cost Reduction Initiative: The layoffs are part of broader efforts to cut costs and extend the company's financial runway.
• Financial Struggles: Better Therapeutics has reported significant net losses and an accumulated deficit, necessitating workforce reductions.
• Strategic Milestones: The company aims to achieve critical milestones such as FDA marketing authorization and the commercial launch of BT-001 for Type 2 diabetes.

Company Statement

"We are also implementing other cost savings measures to further extend our financial runway so we can reach critical milestones over the next few months, including potential FDA marketing authorization and subsequent commercial launch of BT-001 in Type 2 diabetes," Karbe said in the email.

The layoffs are part of a broader strategy to manage financial resources more effectively. By reducing its workforce, Better Therapeutics aims to cut costs and focus on achieving key objectives, such as obtaining FDA approval and launching BT-001 for Type 2 diabetes. This move is crucial for the company's long-term sustainability and growth in a competitive market.

Impact on Workforce and Industry

The layoffs at Better Therapeutics have inevitably led to a leaner workforce, impacting various departments, including research and development. This reduction in staff may slow down some operational processes, but it is a strategic move to streamline efforts towards achieving critical milestones.

In the broader healthcare industry, several companies have also announced layoffs recently, reflecting a trend of cost-cutting measures. For instance, Pear Therapeutics and Akili Interactive have both reduced their workforce to manage financial challenges and focus on core objectives.

Looking Ahead

The layoffs at Better Therapeutics signify a pivotal moment for the company's future, emphasizing a need for financial prudence and strategic focus. Moving forward, the company plans to implement several key initiatives to ensure its sustainability and growth.

• Increased Focus on Core Projects: The company will prioritize its most promising projects, such as BT-001 for Type 2 diabetes, to maximize resource efficiency.
• Enhanced Financial Management: Better Therapeutics will adopt stricter financial controls and budgeting practices to extend its financial runway.
• Strategic Partnerships: The company aims to form alliances with other healthcare organizations to bolster its market position and accelerate product development.

Get Started with Sunset Today!

Sunset helps startups wind down by handling all the legal, tax, and operational burdens, allowing founders to avoid penalties, reduce liabilities, and move on quickly. For personalized guidance and support, contact us to schedule a consultation or learn more. Sign up today and try it out!